Stocks Overview

LAST PRICE
41.8700
TODAY'S CHANGE (%)
Trending Down-0.7400 (-1.7367%)

Bid / Lots
41.2200/ 1
Ask / Lots
44.5000/ 4
Open / Previous Close
42.7000 / 42.6100
Day Range
Low 41.7600
High 43.0800
52 Week Range
Low 31.5200
High 54.9800
Volume
802,954
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 42.61
Time	Volume	RARE
09:32 ET	3759	42.32
09:34 ET	1227	42
09:36 ET	1500	41.83
09:38 ET	200	41.91
09:39 ET	1128	42.02
09:41 ET	2122	42
09:43 ET	1100	42.1
09:45 ET	708	42.12
09:48 ET	200	42.12
09:50 ET	4421	42.225
09:52 ET	2200	42.41
09:54 ET	400	42.55
09:56 ET	6423	42.555
09:57 ET	400	42.55
09:59 ET	2400	42.5
10:01 ET	1200	42.405
10:03 ET	4780	42.62
10:06 ET	400	42.52
10:08 ET	4100	42.5
10:10 ET	2708	42.5
10:12 ET	4833	42.495
10:14 ET	4600	42.52
10:15 ET	43717	42.49
10:17 ET	14295	42.54
10:19 ET	700	42.56
10:21 ET	1184	42.81
10:24 ET	496	42.835
10:26 ET	1797	42.95
10:28 ET	700	42.8763
10:30 ET	1331	42.98
10:32 ET	3861	42.885
10:33 ET	500	42.835
10:35 ET	700	42.85
10:37 ET	500	42.72
10:39 ET	500	42.76
10:42 ET	400	42.755
10:44 ET	200	42.72
10:46 ET	530	42.8
10:48 ET	1444	42.685
10:50 ET	600	42.68
10:51 ET	300	42.59
10:53 ET	1200	42.48
10:55 ET	700	42.58
10:57 ET	1500	42.6
11:00 ET	900	42.36
11:02 ET	700	42.22
11:04 ET	1578	42.01
11:06 ET	2799	41.89
11:08 ET	3136	41.825
11:09 ET	4043	41.915
11:11 ET	1000	42.02
11:13 ET	1200	42
11:15 ET	700	42.033
11:18 ET	5059	41.995
11:20 ET	880	42.05
11:22 ET	1755	42
11:24 ET	950	42.05
11:26 ET	1299	42.09
11:29 ET	1400	42.06
11:31 ET	300	42.01
11:33 ET	10296	42.1
11:38 ET	300	42.12
11:40 ET	800	42.08
11:42 ET	4800	42
11:44 ET	14756	42.02
11:45 ET	3000	42.01
11:47 ET	1000	42
11:49 ET	1600	42
11:51 ET	2500	42.115
11:54 ET	600	42.1
11:56 ET	1600	42.07
11:58 ET	1332	42.27
12:00 ET	4095	42.36
12:02 ET	5117	42.475
12:03 ET	1024	42.41
12:05 ET	600	42.34
12:07 ET	1603	42.392
12:09 ET	2757	42.56
12:12 ET	1658	42.5
12:14 ET	2827	42.51
12:16 ET	637	42.57
12:18 ET	738	42.6
12:20 ET	1161	42.67
12:21 ET	1360	42.5
12:23 ET	300	42.5
12:25 ET	958	42.6
12:27 ET	1141	42.51
12:30 ET	722	42.47
12:32 ET	600	42.4875
12:34 ET	200	42.51
12:36 ET	2712	42.75
12:38 ET	2202	42.68
12:41 ET	227	42.65
12:43 ET	200	42.55
12:45 ET	200	42.5
12:48 ET	500	42.56
12:50 ET	1600	42.69
12:52 ET	1845	42.58
12:54 ET	1318	42.55
12:56 ET	200	42.615
12:57 ET	400	42.57
12:59 ET	200	42.59
01:01 ET	500	42.63
01:03 ET	300	42.595
01:06 ET	300	42.57
01:08 ET	100	42.53
01:10 ET	1395	42.61
01:12 ET	100	42.625
01:14 ET	808	42.595
01:15 ET	1117	42.6
01:19 ET	200	42.52
01:21 ET	1940	42.41
01:24 ET	3181	42.44
01:26 ET	673	42.4486
01:28 ET	100	42.46
01:30 ET	300	42.51
01:32 ET	240	42.51
01:33 ET	200	42.47
01:35 ET	411	42.4553
01:37 ET	626	42.4754
01:39 ET	400	42.495
01:42 ET	600	42.46
01:44 ET	925	42.49
01:46 ET	900	42.52
01:48 ET	500	42.505
01:50 ET	100	42.49
01:51 ET	200	42.49
01:53 ET	4093	42.345
01:55 ET	700	42.35
01:57 ET	2027	42.375
02:00 ET	6267	42.33
02:02 ET	2090	42.295
02:04 ET	2368	42.19
02:06 ET	5112	42.225
02:08 ET	1700	42.09
02:09 ET	2000	42.09
02:11 ET	3024	42.1
02:13 ET	1300	42.08
02:15 ET	700	42.14
02:18 ET	3112	42.035
02:20 ET	2100	41.91
02:22 ET	1522	41.925
02:24 ET	1115	41.915
02:26 ET	1539	41.98
02:27 ET	1924	41.965
02:29 ET	1900	41.94
02:31 ET	3300	41.89
02:33 ET	300	41.78
02:36 ET	1579	41.88
02:38 ET	1600	41.875
02:40 ET	2825	41.94
02:42 ET	800	41.88
02:44 ET	900	41.895
02:45 ET	1200	41.92
02:47 ET	1608	42
02:49 ET	2954	42.06
02:51 ET	2376	42.005
02:54 ET	2897	41.995
02:56 ET	2100	42.02
02:58 ET	2800	42.03
03:00 ET	200	42.04
03:02 ET	7140	42
03:03 ET	2525	42
03:05 ET	1150	42
03:07 ET	1200	42
03:09 ET	1029	42.03
03:12 ET	1700	42.11
03:16 ET	200	42.115
03:18 ET	800	42.08
03:20 ET	2000	42.15
03:21 ET	400	42.19
03:23 ET	2300	42.12
03:25 ET	400	42.15
03:27 ET	900	42.175
03:30 ET	1100	42.15
03:32 ET	1749	42.13
03:34 ET	600	42.135
03:36 ET	900	42.15
03:38 ET	3114	42.225
03:39 ET	1300	42.275
03:41 ET	2717	42.26
03:43 ET	2400	42.11
03:45 ET	3361	42.09
03:48 ET	5364	42.11
03:50 ET	3462	42.07
03:52 ET	4807	42.07
03:54 ET	4978	42.05
03:56 ET	19289	42
03:57 ET	19617	41.96
03:59 ET	21610	41.87

Data delayed at least 15 minutes.

Yesterday
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4), from 22 hours ago by Dow Jones
  22 hours ago by Dow Jones
May 7, 2024
- Ultragenyx to Participate at Bank of America's 2024 Healthcare Conference, from 4:30PM ET on Tuesday May 07, 2024 by Dow Jones
  4:30PM ET on Tuesday May 07, 2024 by Dow Jones
May 6, 2024
- DJ Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity, from 1:45PM ET on Monday May 06, 2024 by Dow Jones
  1:45PM ET on Monday May 06, 2024 by Dow Jones
May 3, 2024
- DJ Ultragenyx Pharma Price Target Maintained With a $107.00/Share by Cantor Fitzgerald, from 11:24AM ET on Friday May 03, 2024 by Dow Jones
  11:24AM ET on Friday May 03, 2024 by Dow Jones
- DJ Ultragenyx Pharma Is Maintained at Neutral by Wedbush, from 9:43AM ET on Friday May 03, 2024 by Dow Jones
  9:43AM ET on Friday May 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRARE Ultragenyx Pharmaceutical Inc	3.5B	-5.2x	---
United StatesFOLD Amicus Therapeutics Inc	2.8B	-19.4x	---
United StatesINSM Insmed Inc	3.7B	-4.7x	---
United StatesAXSM Axsome Therapeutics Inc	3.6B	-12.0x	---
United StatesGMAB Genmab A/S	19.7B	24.9x	+22.71%
United StatesGH Guardant Health Inc	3.1B	-6.5x	---
As of 2024-05-18

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultrarare genetic diseases. Its therapies and clinical-stage pipeline consist of four product categories: biologics, small molecules, AAV gene therapy, and nucleic acid product candidates. The Company’s four approved product candidates include Crysvita (burosumab) for the treatment of X-linked hypophosphatemia (XLH), and tumor-induced osteomalacia (TIO), Mepsevii (vestronidase alfa) for the treatment of mucopolysaccharidosis VII (MPSVII) or Sly Syndrome, Dojolvi (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders (LC-FAOD), and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia (HoFH). Its clinical product candidates include DTX401, DTX301, and UX701. DTX401 for the treatment of glycogen storage disease type la.

Contact Information

Headquarters: 60 Leveroni CtNOVATO, CA, United States 94949-5746
Phone: 415-483-8800
Fax: 415-483-8810

Executives

Independent Director: Daniel Welch
President, Chief Executive Officer, Director: Emil Kakkis
Chief Financial Officer, Executive Vice President, Corporate Strategy: Howard Horn
Executive Vice President, Chief Technical Operations Officer and Gene Therapy Operations: Dennis Huang
Executive Vice President, Chief Legal Officer, General Counsel: Karah Parschauer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.5B
Revenue (TTM)	$442.6M
Shares Outstanding	83.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.61
EPS	$-8.02
Book Value	$3.35
P/E Ratio	-5.2x
Price/Sales (TTM)	7.9
Price/Cash Flow (TTM)	---
Operating Margin	-131.15%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Ultragenyx Pharmaceutical Inc
NASDAQ:RAREUnited States

Search Criteria

Charts

Recent News

Yesterday

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4), from 22 hours ago by Dow Jones

May 7, 2024

Ultragenyx to Participate at Bank of America's 2024 Healthcare Conference, from 4:30PM ET on Tuesday May 07, 2024 by Dow Jones

May 6, 2024

DJ Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity, from 1:45PM ET on Monday May 06, 2024 by Dow Jones

May 3, 2024

DJ Ultragenyx Pharma Price Target Maintained With a $107.00/Share by Cantor Fitzgerald, from 11:24AM ET on Friday May 03, 2024 by Dow Jones

DJ Ultragenyx Pharma Is Maintained at Neutral by Wedbush, from 9:43AM ET on Friday May 03, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar